The prognosis for patients receiving doxorubicin varies depending on the type and stage of cancer, as well as individual patient factors. While doxorubicin is effective against various cancers, its side effects can limit its use in some patients. Advances in supportive care and combination therapies continue to improve outcomes for many patients.
